Checchi Capital Advisers LLC bought a new position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 264 shares of the biotechnology company’s stock, valued at approximately $219,000.
A number of other large investors have also added to or reduced their stakes in the stock. Willner & Heller LLC bought a new stake in Axon Enterprise in the 2nd quarter worth approximately $215,000. 111 Capital bought a new stake in Axon Enterprise in the 2nd quarter worth approximately $267,000. QRG Capital Management Inc. grew its position in Axon Enterprise by 4.6% in the 2nd quarter. QRG Capital Management Inc. now owns 1,303 shares of the biotechnology company’s stock worth $1,079,000 after purchasing an additional 57 shares during the period. Segment Wealth Management LLC grew its position in Axon Enterprise by 11.0% in the 2nd quarter. Segment Wealth Management LLC now owns 4,070 shares of the biotechnology company’s stock worth $3,370,000 after purchasing an additional 404 shares during the period. Finally, Fortis Capital Advisors LLC bought a new stake in Axon Enterprise in the 2nd quarter worth approximately $220,000. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Stock Down 1.0%
AXON opened at $714.60 on Wednesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a fifty-two week low of $420.49 and a fifty-two week high of $885.91. The firm’s fifty day moving average is $757.21 and its 200 day moving average is $710.53. The stock has a market cap of $56.10 billion, a price-to-earnings ratio of 176.44, a price-to-earnings-growth ratio of 28.02 and a beta of 1.41.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the stock. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a research report on Tuesday, August 5th. Northland Securities set a $800.00 price target on shares of Axon Enterprise in a research note on Tuesday, August 5th. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the stock an “overweight” rating in a research note on Friday, July 11th. JPMorgan Chase & Co. lifted their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Finally, Piper Sandler started coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price target on the stock. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $841.64.
Get Our Latest Analysis on AXON
Insider Activity at Axon Enterprise
In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the transaction, the chief executive officer owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. The trade was a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Hadi Partovi bought 1,358 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the purchase, the director owned 237,938 shares in the company, valued at $176,074,120. This represents a 0.57% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 49,932 shares of company stock worth $37,978,216 in the last 90 days. Company insiders own 5.70% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Why is the Ex-Dividend Date Significant to Investors?
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- Top Stocks Investing in 5G Technology
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
